MARKET

SANA

SANA

Sana Biotechnology, Inc.
NASDAQ
3.070
-0.070
-2.23%
After Hours: 3.060 -0.01 -0.33% 19:54 05/15 EDT
OPEN
3.050
PREV CLOSE
3.140
HIGH
3.110
LOW
2.955
VOLUME
3.70M
TURNOVER
--
52 WEEK HIGH
6.55
52 WEEK LOW
1.600
MARKET CAP
854.36M
P/E (TTM)
-3.2705
1D
5D
1M
3M
1Y
5Y
1D
Sana Biotechnology Raises $69 Million Through Equity Offering
TipRanks · 2d ago
Sana Biotechnology Shares Fall on Sale of $69 Million in Shares Through At-The-Market Facility
Dow Jones · 2d ago
Sana Biotechnology raises $69M through ATM share sale
Seeking Alpha · 2d ago
Sana Biotechnology Announces Aggregate Sales Of 21,607,878 Shares With Net Proceeds Of ~$69M Through Its ATM Facility Established With TD Securities
Benzinga · 2d ago
Sana Biotechnology sells 21,607,878 shares via ATM for net proceeds of $69 million
PUBT · 2d ago
SANA BIOTECHNOLOGY ANNOUNCES SALE OF APPROXIMATELY $69 MILLION OF SHARES THROUGH ITS AT-THE-MARKET (ATM) FACILITY
Reuters · 2d ago
Sana Biotechnology (SANA) Receives a Buy from Wedbush
TipRanks · 4d ago
Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy
TipRanks · 5d ago
More
About SANA
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including type 1 diabetes (T1D), oncology, and B cell mediated autoimmune diseases. It develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of therapeutic areas. Its pipeline products include SC451 and UP421. SC451 is its HIP-edited product candidate for the treatment of type 1 diabetes. SC451 is a pluripotent stem cell (PSC)-derived hypoimmune pancreatic islet cell product candidate for the treatment of diabetes, with an initial focus on T1D. Its ex vivo cell engineering platform is focused on engineering hypoimmune cells that engraft, function, and persist in patients by evading immune rejection.

Webull offers Sana Biotechnology Inc stock information, including NASDAQ: SANA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SANA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SANA stock methods without spending real money on the virtual paper trading platform.